Indeed, reduced cGAS and STING expression are associated with poorer survival of patients with lung adenocarcinoma [1] and invasive breast ductal carcinoma [4]; albeit, there is no discernible association among patients with lung squamous cell carcinoma or ovarian cancer [1]. Here, CGAS is linked to ovarian cancer.